OLEMA PHARMACEUTICALS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-2.1M | $-2.1M | $9.0K | — |
| Jun 2020 | $-1.2M | $-1.2M | $6.0K | — |
| Sep 2020 | $-7.5M | $-7.5M | $-10.0K | — |
| Dec 2020 | $-9.0M | $-9.1M | $51.0K | — |
| Mar 2021 | $-11.1M | $-11.5M | $420.0K | $3.2M |
| Jun 2021 | $-8.9M | $-9.3M | $360.0K | $3.9M |
| Sep 2021 | $-12.1M | $-12.2M | $96.0K | $4.2M |
| Dec 2021 | $-18.6M | $-19.3M | $699.0K | $4.6M |
| Mar 2022 | $-17.9M | $-17.9M | $30.0K | $5.0M |
| Jun 2022 | $-26.5M | $-26.5M | $21.0K | $4.7M |
| Sep 2022 | $-18.0M | $-18.1M | $139.0K | $4.3M |
| Dec 2022 | $-19.7M | $-19.9M | $173.0K | $4.9M |
| Mar 2023 | $-20.4M | $-20.4M | — | $4.6M |
| Jun 2023 | $-22.1M | $-22.1M | — | $4.2M |
| Sep 2023 | $-22.7M | $-22.7M | — | $4.1M |
| Dec 2023 | $-18.5M | $-18.5M | — | $4.4M |
| Mar 2024 | $-23.5M | $-23.6M | $153.0K | $4.9M |
| Jun 2024 | $-27.6M | $-27.6M | $6.0K | $5.7M |
| Sep 2024 | $-27.0M | $-27.0M | $0 | $5.6M |
| Dec 2024 | $-26.3M | $-26.3M | $0 | $6.3M |
| Mar 2025 | $-44.0M | $-44.0M | — | $4.4M |
| Jun 2025 | $-29.9M | $-29.9M | — | $4.7M |
| Sep 2025 | $-34.5M | $-34.5M | — | $4.3M |
| Dec 2025 | $-38.3M | $-38.3M | — | $4.3M |
| Mar 2026 | $-46.0M | $-46.0M | — | $10.1M |
| Jun 2026 | $-45.9M | $-45.9M | — | $12.9M |